Precision Medicine Market is Expected to Reach USD 88.64 Billion by 2022

Market research future published a cooked research report on global precision medicine market. The global precision medicine market is expected to grow at a CAGR of 12.48 % during the period 2015 to 2022.

Test the market data and market information presented through more than 60 market data tables and figures spread over 313 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Precision Medicine Market Research Report – Forecast to 2022”.

Market Highlights:
Precision medicine are medicines developed on the basis of information derived from an individual’s genetic profile that helps as a guide for the prevention, diagnosis and treatment of diseases. It involves sequencing the individual genetic makeup and then using that information for the treatment, prevention and mitigation of diseases. The sequencing of the human genome forms the basis of precision medicine. Personal healthcare, integration of wireless technologies with portable healthcare devices, and increase in genetic diseases (due to mutation, UV rays) among others are the major market driving factor for precision medicine. However there remains some constraints such as potential threat to personal data, high diagnostic cost as a barrier, potential risk of hardware or software failure, stringent regulations and standards, lack of awareness about the possible applications of precision medicine, reimbursement policies and regulatory framework, limited knowledge about the application of test and techniques, lack of research and evidences creating hindrances in its application.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/925

The Major Participants Of This Market Are:
Abbott Laboratories, Almac Group, Ltd., Asuragen, Inc., Biomérieux Sa, Cepheid Inc., Cetics Healthcare Technologies Gmbh, Ge Healthcare, Glaxosmithkline Plc, Johnson & Johnson, Laboratory Corporation Of America Holdings, Medtronic, Novartis, Pfizer Inc., Qiagen, Biobase Gmbh, Quest Diagnostics Inc, Randox Laboratories Ltd., Sanofi Pharma, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ab-Biotics Sa, Caris Life Sciences, Healthcore, Inc., Ibm, Innventis, Intel Corporation, Molecular Health Gmbh, Precision For Medicine.

Segmentation:
Global precision medicines market has been segmented on the basis of ecosystem (pharma & biotech companies, diagnostic tool companies, healthcare it/ big data companies, clinical laboratories), by sub-markets (companion diagnostics, biomarker-based test, targeted therapeutics, pharmacogenomics, molecular diagnostics, others), and by therapeutics (cancer/oncology, cardiovascular disease, central nervous system, infectious diseases, others).

Brief TOC for Precision Medicine Market:
1 Report Scope
1.1 Scope of the Study
1.2 Precision Medicine: Report Coverage
1.3 Research Methodology
1.3.1 Research Methodology for the Global Market Study
1.3.1.1 Geographical Analysis
1.3.1.2 Demand Side & Supply Side Analysis
1.3.1.3 Data Synthesis and Bridging
1.3.2 Global Precision Medicine: Research Methodology
1.3.3 Key Data Point Sources
1.3.3.1 Data Points Taken From Secondary Sources
1.3.3.2 Data Points Taken From Primary Sources
1.4 Report Description
2 Executive Summary
3 Market Overview
3.1 Introduction
3.2 Market Timeline
3.3 Key Participants, Strategies & Developments
3.3.1 Government Agencies
3.3.2 Academic Institutions
3.3.3 Device & Service Providers
3.4 Key Market Strategies and Developments
3.4.1 Introduction
3.4.2 Partnerships, Agreements, and Collaborations
3.4.3 Mergers & Acquisitions
3.4.4 Product Development and Launch
3.4.5 Business Expansion/Contracts
3.4.6 Patents, Approvals and Certifications
3.4.7 Others (Events & Recognitions)
Continue…

Regional Analysis:
Depending on geographic region, precision medicine market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally developed countries led by North America is the largest market for Precision medicines. Europe is the second-largest market for Precision medicines. The developed region will lose the lead to the developing in the nearest future.

Intended Audience:
• Global Precision Medicine manufacturers
• Global Precision Medicine suppliers
• Research and Development Laboratories
• Market Research and Consulting Service Providers

Browse Full Report @ https://www.marketresearchfuture.com/reports/precision-medicine-market

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Akash Anand
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.